相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
Karolina Louvanto et al.
CLINICAL INFECTIOUS DISEASES (2020)
Primary cervical screening with high risk human papillomavirus testing: observational study
Matejka Rebolj et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England
Irenjeet Bains et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women
Karoliina Aro et al.
GYNECOLOGIC ONCOLOGY (2019)
What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
Rebecca Landy et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
Murat Gultekin et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
Kine Pedersen et al.
EUROPEAN JOURNAL OF CANCER (2018)
Quality of life assumptions determine which cervical cancer screening strategies are cost-effective
Inge M. C. M. de Kok et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial (vol 320, pg 43, 2018)
G. S. Ogilvie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016
David Mesher et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening
Mairead O'Connor et al.
PREVENTIVE MEDICINE (2018)
Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas
Katia Luz Torres et al.
PLOS ONE (2018)
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Marc Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2017)
Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia
Natasa Vasiljevic et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18
Long Fu Xi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years
Daron G. Ferris et al.
PEDIATRICS (2017)
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
Paolo Giorgi Rossi et al.
PREVENTIVE MEDICINE (2017)
Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55years of age
Tino F. Schwarz et al.
CANCER MEDICINE (2017)
Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)
Roosmarijn Luttmer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Guglielmo Ronco et al.
EUROPEAN JOURNAL OF CANCER (2016)
Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
Mario Poljak et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Need for expanded HPV genotyping for cervical screening
Jack Cuzick et al.
PAPILLOMAVIRUS RESEARCH (2016)
Systematic review of model-based cervical screening evaluations
Diana Mendes et al.
BMC CANCER (2015)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
Warner K. Huh et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2015)
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
Lawrence von Karsa et al.
PAPILLOMAVIRUS RESEARCH (2015)
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
K. G. J. Pollock et al.
BRITISH JOURNAL OF CANCER (2014)
Introduction
Henry C. Kitchener et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination
Cosette M. Wheeler et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
Attila T. Lorincz et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
Hans Ikenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses
Mario Poljak et al.
VACCINE (2012)
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
Inge M. C. M. de Kok et al.
BRITISH MEDICAL JOURNAL (2012)
High-risk human papillomavirus DNA test and p16INK4a in the triage of LSIL: A prospective diagnostic study
I. Tsoumpou et al.
GYNECOLOGIC ONCOLOGY (2011)
Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case-control Study
Long Fu Xi et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document
M. Arbyn et al.
ANNALS OF ONCOLOGY (2010)
Commercially available assays for multiplex detection of alpha human papillomaviruses
Mario Poljak et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
Eduardo L. Franco et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis
I. Tsoumpou et al.
CANCER TREATMENT REVIEWS (2009)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
Jeremy D. Goldhaber-Fiebert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
Guglielmo Ronco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Liquid compared with conventional cervical cytology - A systematic review and meta-analysis
Marc Arbyn et al.
OBSTETRICS AND GYNECOLOGY (2008)
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease
Patti E. Gravitt et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: A systematic review and meta-analysis of non-randomized studies
George Koliopoulos et al.
GYNECOLOGIC ONCOLOGY (2007)
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Jack Cuzick et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Diagnoses and outcomes in cervical cancer screening: A population-based study
RP Insinga et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
分享论文
